Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats

Biomarkers in Medicine

Volumn 8, Issue 1, 2014, Pages 85-94

  Zhang, Qin ^a   Davis, Kelly J ^b   Hoffmann, Dana ^c   Vaidya, Vishal S ^c   Brown, Ronald P ^a   Goering, Peter L ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

chronic kidney disease; hypertension; obesity; urine biomarker

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CHOLESTEROL; CLUSTERIN; CREATININE; CYSTATIN C; FIBRINOGEN; GLUCOSE; NITROGEN; OSTEOPONTIN; TRIACYLGLYCEROL; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FIBRINOGEN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NONHUMAN; OBESITY; RAT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

AGING; ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPERTENSION; OBESITY; RATS; RATS, INBRED SHR; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS;

EID: 84890681147     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.106     Document Type: Article

References (32)

1. Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief 48, 1-8 (2010
2. Ogden CL, Carroll MD, Kit BK et al. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 82, 1-8 (2012
3. Kramer H, Luke A, Bidani A et al. Obesity and prevalent and incident CKD: The hypertension detection and follow-up program. Am. J. Kidney Dis. 46(4), 587-594 (2005
4. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: A systematic review and meta-Analysis. Kidney Int. 73(1), 19-33 (2008
5. Kincaid-Smith P. Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'. J. Hypertens. 22(6), 1051-1055 (2004
6. Narkiewicz K. Obesity and hypertension-The issue is more complex than we thought. Nephrol. Dial. Transplant. 21(2), 264-267 (2006
7. Schnellmann RG. Toxic responses of the kidney. In: Casarett and Doull's Toxicology-The Basic Science of Poisons (7th Edition). Klaassen C (Ed.). McGraw-Hill, NY, USA (2008
8. Dieterle F, Sistare F, Goodsaid F et al. Renal biomarker qualification submission: A dialog between the FDA-EMEA and predictive safety testing consortium. Nat. Biotechnol. 28(5), 455-462 (2010
9. Bonventre JV, Vaidya VS, Schmouder R et al. Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 28(5), 436-440 (2010
10. Che M, Xie B, Xue S et al. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Nephron Clin. Pract. 115(1), c66-c72 (2010
11. Han WK, Bailly V, Abichandani R et al. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 62(1), 237-244 (2002
12. Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 14(6), 423-431 (2009
13. Vaidya VS, Waikar SS, Ferguson MA et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin. Transl. Sci. 1(3), 200-208 (2008
14. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48, 463-493 (2008
15. Hall IE, Yarlagadda SG, Coca SG et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J. Am. Soc. Nephrol. 21(1), 189-197 (2010
16. Hoffmann D, Bijol V, Krishnamoorthy A et al. Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury. Am. J. Pathol. 181(3), 818-828 (2012
17. Krishnamoorthy A, Ajay AK, Hoffmann D et al. Fibrinogen b-derived Bb(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood 118(7), 1934-1942 (2011
18. Parikh CR, Edelstein CL, Devarajan P et al. Biomarkers of acute kidney injury: Early diagnosis, pathogenesis, and recovery. J. Investig. Med. 55(7), 333-340 (2007
19. Zappitelli M, Krawczeski CD, Devarajan P et al. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int. 80(6), 655-662 (2011
20. Fuchs TC, Hewitt P. Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: What we know and what we need to know. Biomarkers Med. 5(6), 763-779 (2011
21. Zhou Y, Vaidya VS, Brown RP et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol. Sci. 101(1), 159-170 (2008
22. McCarron DA, Lucas PA, Shneidman RJ et al. Blood pressure development of the spontaneously hypertensive rat after concurrent manipulations of dietary Ca2+ and Na+. Relation to intestinal Ca2+ fluxes. J. Clin. Invest. 76(3), 1147-1154 (1985
23. Brott DA, Bentley P, Nadella MV et al. Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependent. Toxicology 303, 133-138 (2013
24. Ernsberger P, Koletsky RJ, Friedman JE. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: A model of syndrome X. Ann. NY Acad. Sci. 892, 272-288 (1999
25. Friedman JE, Ishizuka T, Liu S et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am. J. Physiol. 273(5 Pt 1), E1014-E1023 (1997
26. Koletsky RJ, Boccia J, Ernsberger P. Acceleration of renal disease in obese SHR by exacerbation of hypertension. Clin. Exp. Pharmacol. Physiol. Suppl. 22(1), S254-S256 (1995
27. Koletsky S. Animal model: Obese hypertensive rat. Am. J. Pathol. 81(2), 463-466 (1975
28. Ernsberger P, Koletsky RJ, Collins LA et al. Renal angiotensin receptor mapping in obese spontaneously hypertensive rats. Hypertension 21(6 Pt 2), 1039-1045 (1993
29. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase-Associated lipocalin (NGAL) and progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4(2), 337-344 (2009
30. Peralta CA, Shlipak MG, Judd S et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-To-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305(15), 1545-1552 (2011
31. Gorriz JL, Martinez-Castelao A. Proteinuria: Detection and role in native renal disease progression. Transplant. Rev. (Orlando) 26(1), 3-13 (2012
32. Redon J, Morales-Olivas F, Galgo A et al. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension. J. Am. Soc. Nephrol. 17(12 Suppl. 3), S236-S245 (2006